Susan E. Chisholm

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

Annemieke de Jong, Terence W O’Neill, A.Y Khan et al. · Vaccine · 2002 · 166 citations

Medicine, Immunology, Infectious Diseases +14

A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease

M. E. G. Boursnell, Claire Entwisle, D M Blakeley et al. · The Journal of Infectious Diseases · 1997 · 158 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function

Pedro Roda‐Navarro, Mar Valés‐Gómez, Susan E. Chisholm et al. · Proceedings of the National Academy of Sciences · 2006 · 96 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome Inhibitors

Mar Valés‐Gómez, Susan E. Chisholm, Robin L. Cassady-Cain et al. · Cancer Research · 2008 · 94 citations

Life Sciences, Cell Biology, Immunology +15

Recognition of Vaccinia Virus-Infected Cells by Human Natural Killer Cells Depends on Natural Cytotoxicity Receptors

Susan E. Chisholm, Hugh T. Reyburn · Journal of Virology · 2006 · 90 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17